论文信息 - CD34 immunoperoxidase staining for the diagnosis of myelodysplastic syndromes and chronic myeloid leukaemia. - 字舞流文

CD34 immunoperoxidase staining for the diagnosis of myelodysplastic syndromes and chronic myeloid leukaemia.

[1] E. Kaiserling,et al. QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens. , 1995, Journal of clinical pathology.

[2] A. Cortelezzi,et al. CD34 immunohistochemistry of bone marrow biopsies: Prognostic significance in primary myelodysplastic syndromes , 1994, American journal of hematology.

[3] N. Heerema,et al. CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia. , 1994, American journal of clinical pathology.

[4] G. Cattoretti,et al. Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment. , 1993, Leukemia.

[5] G. Cattoretti,et al. Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. , 1991, Leukemia.